Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,434 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients.
Nakamura R, Arakawa N, Tanaka Y, Uchiyama N, Sekine A, Mashimo Y, Tsuji K, Kagawa T, Sato K, Watanabe M, Aiso M, Hiasa Y, Takei Y, Ohira H, Ayada M, Tsukagoshi E, Maekawa K, Tohkin M, Saito Y, Takikawa H. Nakamura R, et al. Among authors: saito y. Hepatol Res. 2023 May;53(5):440-449. doi: 10.1111/hepr.13874. Epub 2023 Jan 14. Hepatol Res. 2023. PMID: 36583370
Differential Effects of HLA-B∗15:11 and HLA-A∗31:01 on Carbamazepine-Induced Cutaneous Adverse Reactions.
Fukunaga K, Tsukagoshi E, Kurata M, Mizukawa Y, Niihara H, Morita E, Watanabe Y, Yamaguchi Y, Watanabe H, Nakajima S, Nomura T, Kabashima K, Tohyama M, Azukizawa H, Asada H, Hasegawa A, Hama N, Ozeki T, Mashimo Y, Sekine A, Matsunaga K, Tanaka Y, Nakamura R, Abe R, Mushiroda T, Saito Y. Fukunaga K, et al. Among authors: saito y. J Invest Dermatol. 2024 Apr;144(4):908-911.e7. doi: 10.1016/j.jid.2023.09.282. Epub 2023 Oct 30. J Invest Dermatol. 2024. PMID: 37914023 No abstract available.
Association of HLA-A∗11:01, HLA-B∗39:01, and HLA-B∗56:03 with salazosulfapyridine-induced cutaneous adverse drug reactions.
Fukunaga K, Tsukagoshi E, Nakamura R, Matsunaga K, Ozeki T, Watanabe H, Hasegawa A, Hama N, Kurata M, Mizukawa Y, Watanabe Y, Yamaguchi Y, Niihara H, Morita E, Asada H, Abe R, Saito Y, Mushiroda T. Fukunaga K, et al. Among authors: saito y. J Allergy Clin Immunol Pract. 2024 May;12(5):1355-1358.e3. doi: 10.1016/j.jaip.2024.02.041. Epub 2024 Apr 11. J Allergy Clin Immunol Pract. 2024. PMID: 38613561 No abstract available.
High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4∗16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database.
Adachi K, Ohyama K, Tanaka Y, Sato T, Murayama N, Shimizu M, Saito Y, Yamazaki H. Adachi K, et al. Among authors: saito y. Drug Metab Pharmacokinet. 2023 Apr;49:100486. doi: 10.1016/j.dmpk.2022.100486. Epub 2022 Dec 7. Drug Metab Pharmacokinet. 2023. PMID: 36746706
9,434 results